Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. Functional gastrointestinal disorders from childhood to adulthood
  3. Functional gastrointestinal disorders: a set of diseases defined in correlation with the intestinal microbiota
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Functional gastrointestinal disorders from childhood to adulthood
  3. Functional gastrointestinal disorders: a set of diseases defined in correlation with the intestinal microbiota
Gastroenterology

Functional gastrointestinal disorders: a set of diseases defined in correlation with the intestinal microbiota

Functional gastrointestinal disorders
Pediatrics Gastroenterology

The intestinal microbiota: etiologic factor or avenue of therapeutic response for FGIDs? Both assumptions are progressively confirmed and completed as scientific advances are made. Nevertheless, the use of diagnostic classification is met with limits in clinical practice and leads to frequent delays in diagnosis. Mechanisms involved in the microbiota-FGID relation still need to be specified, including neuroendocrine processes involving the gut-brain axis.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

Sections

About this article

Created 15 October 2019
Updated 27 October 2021

CHANGE IN STATUS

Viewed as shameful in many cultures, functional GI disorders were long regarded as a private matter and related to stress and feelings rather than an easily identifiable organic trouble. The perception changed in the years 1960’s thanks to technical and scientific advances: works on etiology and pathophysiology provided a foundation for an organic understanding of FGIDs. In the following decades, the “all physiological” vision was gradually abandoned and the related psychosocial processes were deepened, before the standard modern biopsychological model was ultimately reached.

ROME, CRADLE OF CLASSIFICATION

In the fourth edition of its work of reference (Rome IV), the Rome Foundation proposes a definition of FGIDs collaboratively designed by a panel of experts: they include disorders of the gut-brain axis, i.e. a “group of disorders classified based on gastrointestinal symptoms, related to a combination of the following: motility disturbance, visceral hypersensitivity, deterioration of the mucosa and immune functions, change in intestinal microbiota and alteration of central nervous system functions”. The result of that review is a precise categorization of FGIDs as well as a rationale for their study and treatment.

Functional gastrointestinal disorders

53 DIFFERENT TYPES OF FGID

The Rome IV classification is based on symptomatic criteria grouped by anatomic region (esophageal, gastroduodenal, intestinal, biliary and anorectal). However, symptom location by itself is not enough, especially regarding irritable bowel syndrome (IBS), functional dyspepsia, or abdominal pain syndrome (hard to place and influenced by global effects resulting from deregulation of signaling pathways between central and enteric nervous systems) mediated by the central nervous system. Its 33 items for adults and 20 for newborns, children and teenagers ensure a precise diagnosis and facilitate the implementation of targeted patient care. In this regard, the Rome Foundation insisted on the importance of not limiting therapeutic approaches to medication alone and recommends a biopsychosocial approach to face the variability of cases and individual expectations of patients suffering from FGIDs.

Functional gastrointestinal disorders 2

MICROBIOTA: A MAJOR INTESTINAL PLAYER

The intestinal microbiota has a complex influence on the metabolism, nutrition and immune functions of the host. Its alteration plays a central role in FGIDs.3,4 Dysbiosis has been specifically studied regarding IBS and studies in animals have shown that this imbalance might be involved in the observed visceral hypersensitivity (via endoluminal bile acids), as well as in gastrointestinal dysmotility through the expression of enzymes involved in the synthesis of neuromodulators (gamma-aminobutyric acid [GABA], for instance) and products of colonic fermentation (gas or short-chain fatty acids, SCFA). Finally, dysbiosis seems to promote the disruption of the intestinal barrier: increased intestinal permeability would thus improve the crossing of bacterial antigens responsible for low-grade inflammation leading to sensitization of sensory afferent fibers of the enteric nervous system.3,4

PROMISING APPROACH

Heterogeneity of FGIDs and contradictory results in terms of bacterial composition depending on studies and methods do not allow microbiota and its metabolites to be used as relevant markers for diagnosis, monitoring of the progression of the disease, or treatment response. Literature confirms however the importance of diversity and composition of the intestinal microbiota in the pathophysiology of FGIDs, and consequently the potential impact of approaches related to modulations of intestinal bacterial populations.

Image
Functional-gastrointestinal-infography3
Sources

2 Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016;S0016-5085(16)00223-7.

3 Ringel Y. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders. Gastroenterol Clin North Am. 2017;46(1):91-101.

4 Marteau P, Doré J. Gut microbiota, a full fledged organ. John Libbey Eurotext. 2017

Tags
IBS Gut-brain axis Dysbiosis Gut health Functional gastrointestinal disorders

en_view en_sources

    Focus
    Functional gastrointestinal disorders from childhood to adulthood
    • Pathophysiology
      • Functional gastrointestinal disorders: a set of diseases defined in correlation with the intestinal microbiota
      • Focus on the gut-brain axis
    • FGIDS: from infants to adults
      • In newborns
      • In children and adolescents
      • In adults
    • What could be the role of microbiota modulation?
      • Modulation of the microbiota by FMT: controversial results
      • FODMAP-free diet: not for all patients
      • Probiotics: what are the benefits?
    • Expert opinion
      • Dr. Marc Bellaiche: Managing FGIDs in children
    Created 15 October 2019
    Updated 27 October 2021

    About this article

    To know more about this topic.

    Main topic

    Functional gastrointestinal disorders

    Medical practice

    Pediatrics Gastroenterology

    Content type

    Dossier detail
    Functional gastrointestinal disorders from childhood to adulthood
    Focus on the gut-brain axis
    Focus

    Functional gastrointestinal disorders from childhood to adulthood

    Pathophysiology

    Functional gastrointestinal disorders: a set of diseases defined in correlation with the intestinal microbiota Focus on the gut-brain axis

    FGIDS: from infants to adults

    In newborns In children and adolescents In adults

    What could be the role of microbiota modulation?

    Modulation of the microbiota by FMT: controversial results FODMAP-free diet: not for all patients Probiotics: what are the benefits?

    Expert opinion

    Dr. Marc Bellaiche: Managing FGIDs in children

    Continue reading

    News

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irritable Bo...

    Find out more

    Everything you need to know about Irritable Bowel Syndrome (IBS)

    Accrediting training, infographics, expert’s video, thematic folder, news… Biocodex Microbiota Institute pr...

    Find out more

    Infographics to share with your patients!

    Download original graphic material to explain to your patients the role of the microbiota in their daily he...

    Find out more
    13.01.2023

    Insomnia in seniors: a link with the gut microbiota

    Read the article

    Gut Microbiota #17

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Impact of beer and non alcoholic comsumption on the gut microbiota

    By Pr. Bernd SchnablDivision of Gastroenterology, San Diego Digestive Diseases Research Center (SDDRC), UC ...

    Find out more

    Gut Microbiota # 16

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Highlights from the UEGW

    By Dr. Lucas WautersGastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium

    Find out more
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    23.01.2023

    Idiopathic urethritis in men: new infectious etiologies?

    Read the article

    Impact of beer and non alcoholic comsumption on the gut microbiota

    By Pr. Bernd SchnablDivision of Gastroenterology, San Diego Digestive Diseases Research Center (SDDRC), UC ...

    Find out more

    Skin Microbiota #17

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo